Fintech PR
SFB and TWSE shine spotlight on Taiwan’s capital market with highly-anticipated “Taiwan Day” in London
LONDON and HONG KONG and SINGAPORE, March 5, 2024 /PRNewswire/ — In early March, Chen-Shan Chang, Director-General of the Securities and Futures Bureau (the “SFB”) and Sherman Lin, Chairman and CEO of the Taiwan Stock Exchange (the “TWSE”) led a team to Europe, marking the first foreign investment attraction trip of the year. The visit included meetings with dozens of influential European institutions, ranging from exchanges, index companies, investment institutions, and large asset management firms. A much-anticipated highlight was the “Taiwan Day” event held on 5 March, which brought together over 50 prominent investors from the UK to gain insights into the latest market reform measures and the outlook for Taiwan’s stock market.
Held in London, the “Taiwan Day” proved to be a resounding response to the recent call by Dr. Tien-Mu Huang, Chairperson of the Financial Supervisory Commission (the “FSC”), for securities-related institutions to continuously enhance international connectivity and promote the strengths and reforms of Taiwan’s capital market. During the event, the prominent European institutional investors in attendance were highly impressed by a wide array of strengths of Taiwan’s stock market, such as its high-tech cluster characteristics, outstanding ESG performance, and foreign investment-friendly environment.
Taiwan’s representative for the UK, Vincent Chin-Hsiang Yao shared how the pandemic has underscored the crucial role of Taiwanese enterprises in the global supply chain. The “Taiwan Day” not only provided participants an opportunity to gain a profound understanding of the advantages offered by Taiwanese enterprises, but also aimed to foster a solid foundation for enhancing the ties between Taiwan and the UK and promoting mutual prosperity.
Chang, in his articulation, highlighted Taiwan’s commitment to attract foreign investment in recent years, as demonstrated by the joint efforts with the TWSE to visit institutional investors in major financial centers around the world since last year, and the aspiration to establish Taiwan’s capital market as a foreign investment-friendly environment through direct dialogue in the future.
Lin continued by illustrating the UK’s role as a substantial investment source for Taiwan, and the Taiwan-UK partnership further cemented by the “Bilateral Enhanced Trade Partnership Arrangement” signed in last November. Going forward, Taiwan will continue to strengthen the development of its high-tech industry, create an ESG-friendly environment, and actively seek feedback from investors to consolidate the role of Taiwan’s capital market.
Shin-Chung Chen, Senior Vice President of the TWSE, took the floor to present the compelling attributes of Taiwan’s capital market. These include Taiwan’s robust economic development with a projected GDP growth rate of over 3% in 2024 as well as the prominent rankings on a global scale. According to data of the World Federation of Exchanges, Taiwan’s stock exchange ranks 7th, 12th and 16th in terms of turnover, trading value and market capitalization, respectively. In 2023, over 80% of listed companies distributed cash dividends and foreign ownership accounted for over 40%. Additionally, Taiwan listed companies and emerging technology firms play a pivotal role in the up and midstream supply chain of artificial intelligence (AI). These companies not only prioritize ESG-related development, but also maintain a steadfast commitment to continuously fostering a foreign investment-friendly environment which welcomes international investors into Taiwan’s market.
Kuo-Jung Cheng, Deputy Director of the SFB, then provided a comprehensive introduction to a series of investor-friendly initiatives poised to attract overseas capital into Taiwan’s capital market, enhancing the appeal of Taiwan’s market among foreign investors through more diversified investment opportunities, flexible sources of investment funds, and convenient digital services. Cheng also gave an in-depth overview of recent key regulatory reforms and forward-looking policies related to sustainability, green finance, and net-zero emissions, underscoring Taiwan’s commitment to aligning its market with international standards, all the while leading market participants in promoting the characteristics and advantages of Taiwan’s market.
Following the meeting, the TWSE arranged one-on-one sessions with investors to delve into specific areas of interest, including ESG and trading systems. These sessions allowed the TWSE to actively respond to investor questions and gather feedback with a view of continuing to bolster investor confidence. The institutional investors attending the event responded positively to the resilience of Taiwan’s economic fundamentals, its central role in the semiconductor and information and communications technology (ICT) industries, and the focus on the development of the ESG ecosystem. They also highly appreciated the authority and the TWSE for their attentive listening to investor opinions, proactive response, and thorough explanations on important issues of concern.
Looking ahead, the TWSE will continue to encourage foreign investment opportunities and to promote the investment niche offered by Taiwan stocks, actively seeking feedback from global key institutional investors for the development of Taiwan market. Through these efforts, the TWSE aims to enhance Taiwan’s international presence and deepen the investment community’s understanding of the advantages and resilience of Taiwan’s capital market.
SFB and TWSE jointly host “Taiwan Day” event in London
About TWSE
The Taiwan Stock Exchange (the “TWSE”) started operations on February 9, 1962. The TWSE is responsible for operating and advancing Taiwan securities market. The TWSE’s primary business operations include listing, trading, settlement and surveillance. These comprise listing promotion and review, post-listing supervision and corporate governance, maintaining market trading and order, securities firms’ services, investor protection, clearing and settlement operations, safeguarding against market defaults and the monitoring of illegal transactions. The Exchange provides comprehensive services to the stock market.
Logo – https://mma.prnewswire.com/media/2354914/Chen_Shan_Chang_Director_General_Securities_Futures_Bureau__Left__Vincent_Chin_Hsiang_Yao.jpg
Logo – https://mma.prnewswire.com/media/2354915/Group_meeting__Taiwan_Day__event_London.jpg
View original content:https://www.prnewswire.co.uk/news-releases/sfb-and-twse-shine-spotlight-on-taiwans-capital-market-with-highly-anticipated-taiwan-day-in-london-302079825.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News7 days ago
Trakx launches a new product: Trakx USDc Earn CTI powered by OpenTrade
-
Latest News3 days ago
Letter from Gatemore Capital Management LLP to Elementis PLC
-
Latest News6 days ago
Money20/20 Asia 2024: Days Two Roundup
-
Latest News6 days ago
Stripe Unveils Unbundled Payments Strategy in Fintech Pivot
-
Latest News3 days ago
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
-
Latest News7 days ago
Sungrow Released Annual Report 2023: Operating Revenue Witnessed A Robust Growth of 79.5%
-
Latest News7 days ago
Chubb Report: Damage During Home Renovations and from Extreme Weather are Top Concerns of U.K. High Earners
-
Latest News5 days ago
Former Tesla executive Tim Newell is set to spin off Aspiration’s consumer financial services division.